Table 2.
Descriptive numerical data for the whole study population
|
Variable
|
Data
|
| MELD score | 16 ± 4 |
| Child score | 10 ± 2 |
| Donors’ age (yr) | 27 ± 6 |
| Donors’ BMI (kg/m2) | 24 ± 3 |
| Recipient's age (yr) | 50 ± 8 |
| Recipient's BMI (kg/m2) | 28 ± 4 |
| Total bilirubin (mg/dL) | 2.6 (1.9-3.8) |
| Direct bilirubin (mg/dL) | 1.3 (0.7-2.1) |
| Alkaline phosphatase (IU/L) | 104 ± 48 |
| Gamma-glutamyl transferase (IU/L) | 36 (19-61) |
| Platelets (109/L) | 79 ± 35 |
| Cold ischemia time (min) | 49 ± 24 |
| Warm ischemia time (min) | 48 ± 20 |
| Graft arterialization time (min) | 141 ± 51 |
| Time to biliary infection (d) | 16 (11-30) |
| Time to biliary stricture (d) | 150 (120-218) |
| Time to mortality (d) | 285 (55-808) |
| Time to chronic graft rejection (d) | 490 (230-920) |
| Time to recurrent HCV (d) | 391 (180-714) |
| Time to graft failure (d) | 556 (135-1267) |
Data are presented as mean ± SD or median and range. MELD: Model for end-stage liver disease; BMI: Body mass index; HCV: Hepatitis C virus.